Trial Profile

A Phase 2b clinical trial of MH002 in patients with mild-to-moderate ulcerative colitis.

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 28 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MH 002 (Primary)
Indications Ulcerative colitis
Focus Therapeutic Use

Most Recent Events

28 Oct 2025 New trial record
04 Sep 2025 According to a MRM Health media release, Funding to support Phase 2b trial with MRM Healths lead program MH002 in ulcerative colitis and advance two additional programs to IND approval.Proceeds will enable MRM Health to complete a Phase 2b clinical trial for its lead program MH002 in patients suffering from mild-to-moderate ulcerative colitis.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com